Whalen v. Stryker Corp.

783 F. Supp. 2d 977, 2011 U.S. Dist. LEXIS 23303, 2011 WL 845822
CourtDistrict Court, E.D. Kentucky
DecidedMarch 8, 2011
DocketCivil Action 10-391-KSF
StatusPublished
Cited by15 cases

This text of 783 F. Supp. 2d 977 (Whalen v. Stryker Corp.) is published on Counsel Stack Legal Research, covering District Court, E.D. Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Whalen v. Stryker Corp., 783 F. Supp. 2d 977, 2011 U.S. Dist. LEXIS 23303, 2011 WL 845822 (E.D. Ky. 2011).

Opinion

OPINION & ORDER

KARL S. FORESTER, Senior District Judge.

Currently before the Court is the motion of the defendants, Stryker Corporation and Stryker Sales Corporation (collectively “Stryker”), to dismiss the plaintiffs complaint for failure to state a claim upon which relief can be granted pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure. This motion is fully briefed and is ripe for review.

I. FACTUAL AND PROCEDURAL BACKGROUND

On June 29, 2006, the plaintiff, Cheryl Whalen (“Whalen”) underwent arthroscopic shoulder surgery at UK Healthcare Good Samaritan Hospital in Lexington, Kentucky. During surgery, her orthopedic surgeon inserted a Stryker pain pump that injected local anesthetic products into her shoulder joint on a continuous basis for up to 72 hours or more following the surgery. Although Whalen continued to seek medical care for her shoulder through 2010, she contends that she was not aware, nor could she have reasonably discovered through the exercise of reasonable diligence, that she had been injured and was suffering from various injuries related to or caused by the Stryker pain pump.

Whalen alleges that she did not learn of the alleged association between the Stryker pain pump and a condition known as glenohumeral chondrolysis until November 13, 2009, when the Food and Drug Administration (“FDA”) published its Postmarket Drug Safety Bulletin. According to Whalen, she then learned that the pain pump works by bathing the surgical site with a constant source of local anesthetic which is delivered via a “soaker” catheter implanted during surgery. Whalen contends that the anesthetic delivered by the pain pump *979 is toxic to the cartilage which makes up the articular surfaces in the shoulder, known as the chondral cartilage. Once the anesthetic kills the chrondrocytes (the cells that make up the chrondral cartilage), the shoulder is irreparably damaged and will not regenerate — a process known as glenohumeral chondrolysis which results in constant pain and loss of full use of the shoulder and/or arm. There is no effective treatment for glenohumeral chondrolysis, and that many patients ultimately require shoulder replacements.

Whalen contends that Stryker knew or should have known about the correlation between its pain pumps and glenohumeral chondrolysis, and still promoted, sold, advertised, and marketed the use of the pain pumps for use after shoulder surgery. She now claims that as a result of her use of the pain pump, she has experienced and/or is at risk of experiencing serious and dangerous side effects including but not limited to, loss of shoulder mobility and range of motion and loss of use of the shoulder.

On November 11, 2010, W/halen filed this products liability action in this Court [DE # 1]. Her Complaint asserts the following claims: (1) negligence; (2) strict products liability; (3) breach of express warranty; (4) breach of implied warranties; (5) fraudulent misrepresentation; (6) fraudulent concealment; (7) negligent misrepresentation; (8) fraud and deceit; and (9) violation of state consumer fraud and deceptive trade practices act. Although this action was filed more than four years after her surgery, WZhalen contends that the statute of limitations has been tolled because she first learned that she had suffered a wrongful injury, separate and apart from her underlying pre-existing shoulder injury, on November 13, 2009 when the FDA published its Postmarket Drug Safety Bulletin. Additionally, Whalen contends that Stryker’s fraudulent concealment of the association between the use of its products and chondrolysis acted to toll the statute of limitations. Stryker has now filed its motion to dismiss, arguing that WZhalen’s Complaint fails to state a claim upon which relief can be granted.

II. ANALYSIS

A. MOTION TO DISMISS STANDARD

To withstand a motion to dismiss, a complaint must plead “enough facts to state a claim to relief that is plausible on its face.” Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 547, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007).

Wfiiile a complaint attacked by a Rule 12(b)(6) motion to dismiss does not need detailed factual allegations, a plaintiffs obligation to provide the grounds of his entitlement to relief requires more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do. Factual allegations must be enough to raise a right to relief above the speculative level.

Id. at 555, 127 S.Ct. 1955(citations and quotation marks omitted). See also Association of Cleveland Fire Fighters v. City of Cleveland, Ohio, 502 F.3d 545, 548 (6th Cir.2007). In ruling upon a motion to dismiss for failure to state a claim pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure, all of a plaintiffs allegations are presumed true, and the complaint is construed in the light most favorable to the plaintiff. Hill v. Blue Cross and Blue Shield of Michigan, 409 F.3d 710, 716 (6th Cir.2005).

A district court may not grant a Rule 12(b)(6) motion because it does not believe the complaint’s factual allegations. Wright v. MetroHealth Medical Center, 58 F.3d 1130, 1138 (6th Cir.1995). However, *980 “[cjonclusory allegations or legal conclusions masquerading as factual allegations will not suffice to prevent a motion to dismiss.” Mezibov v. Allen, 411 F.3d 712, 716 (6th Cir.2005).

B. ANALYSIS

Although Stryker’s motion seeks a dismissal on all of Whalen’s claims, Whalen has agreed to voluntarily dismiss her claims for breach of express warranty, breach of implied warranty, and her claims based on the Kentucky .Consumer Protection Act. Accordingly, the Court will dismiss these claims without any further analysis. Remaining before the Court, then, is Stryker’s motion to dismiss Whalen’s claims for negligence and strict liability based on the statute of limitations, its motion to dismiss Whalen’s claims for fraud for failure to plead with particularity as required by Rule 9(b) of the Federal Rules of Civil Procedure, and its motion to dismiss Whalen’s claim for punitive damages for failure to show by clear and convincing evidence that Stryker acted with the requisite level of culpability.

1. WHALEN’S CLAIMS OF NEGLIGENCE AND STRICT LIABILITY ARE NOT BARRED BY THE STATUTE OF LIMITATIONS

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
783 F. Supp. 2d 977, 2011 U.S. Dist. LEXIS 23303, 2011 WL 845822, Counsel Stack Legal Research, https://law.counselstack.com/opinion/whalen-v-stryker-corp-kyed-2011.